Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-26 Sale |
2024-02-27 4:44 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
883 | $425.7 | $375,893 | 15,972 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 4:37 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
5,034 | $425.7 | $2,142,974 | 49,831 (Indirect Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 4:29 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
883 | $425.7 | $375,893 | 7,965 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 4:24 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,239 | $425.7 | $1,804,542 | 25,813 (Direct) |
View |
| 2024-02-21 Sale |
2024-02-23 4:28 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
360 | $421.77 | $151,837 | 59,467 (Direct) |
View |
| 2024-02-21 Sale |
2024-02-23 4:20 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
3,191 | $421.77 | $1,345,868 | 68,245 (Indirect Direct) |
View |
| 2024-02-21 Sale |
2024-02-23 4:16 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
1,201 | $421.77 | $506,546 | 18,509 (Direct) |
View |
| 2024-02-21 Sale |
2024-02-23 4:12 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
3,603 | $421.77 | $1,519,637 | 59,579 (Indirect Direct) |
View |
| 2024-02-21 Sale |
2024-02-23 4:10 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,002 | $421.77 | $1,266,154 | 34,022 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 4:43 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
480 | $420.79 | $201,979 | 59,827 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 4:38 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
4,254 | $420.79 | $1,790,041 | 71,436 (Indirect Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 4:23 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
801 | $420.79 | $337,053 | 19,710 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 4:19 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,804 | $420.79 | $2,021,475 | 63,182 (Indirect Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 4:13 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,002 | $420.79 | $1,684,002 | 37,024 (Direct) |
View |
| 2024-02-14 Sale |
2024-02-16 4:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
9,011 | $419.1 | $3,776,528 | 18,336 (Indirect Direct) |
View |
| 2024-02-12 Sale |
2024-02-14 4:04 pm |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
3,393 | $419.42 | $1,423,104 | 27,347 (Indirect Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 5:23 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
314 | $420.24 | $131,955 | 68,179 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 5:15 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
3,222 | $420.24 | $1,354,013 | 81,811 (Indirect Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 4:56 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer |
1,738 | $418.77 | $727,822 | 18,280 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 4:54 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
913 | $420.24 | $383,679 | 23,137 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 4:51 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,295 | $420.24 | $1,804,931 | 75,858 (Indirect Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 4:48 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
1,374 | $420.24 | $577,410 | 9,676 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 4:46 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,145 | $420.24 | $1,321,655 | 47,588 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-23 Tax Withholding |
2024-02-27 4:44 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
1,654 | $431.79 | 15,972 (Direct) |
View |
| 2024-02-23 Tax Withholding |
2024-02-27 4:37 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,714 | $431.79 | 49,831 (Direct) |
View |
| 2024-02-23 Tax Withholding |
2024-02-27 4:29 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
828 | $431.79 | 7,965 (Direct) |
View |
| 2024-02-23 Tax Withholding |
2024-02-27 4:24 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,970 | $431.79 | 25,813 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-21 4:49 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
2,812 | $420.58 | 56,892 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:49 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
3,750 | $424.01 | 56,892 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-21 4:43 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
3,373 | $420.58 | 59,827 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:43 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
4,499 | $424.01 | 59,827 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-21 4:38 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
2,623 | $420.58 | 71,436 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:38 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
3,498 | $424.01 | 71,436 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-21 4:34 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
4,118 | $420.58 | 14,218 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-21 4:29 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
7,019 | $420.58 | 145,893 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:29 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
9,359 | $424.01 | 145,893 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-21 4:26 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
2,812 | $420.58 | 40,248 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:26 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
3,750 | $424.01 | 40,248 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-21 4:23 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
1,125 | $420.58 | 19,710 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:23 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
1,501 | $424.01 | 19,710 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-21 4:19 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
3,373 | $420.58 | 63,182 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:19 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,499 | $424.01 | 63,182 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-21 4:13 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,812 | $420.58 | 37,024 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:13 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,750 | $424.01 | 37,024 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 5:34 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
2,607 | $422.74 | 63,454 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 5:23 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
2,100 | $422.74 | 68,179 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 5:15 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
2,022 | $422.74 | 81,811 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 5:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
8,255 | $422.74 | 162,271 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 5:01 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
2,100 | $422.74 | 46,810 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 4:56 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer |
1,588 | $422.74 | 18,280 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 4:54 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
832 | $422.74 | 23,137 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 4:51 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
3,177 | $422.74 | 75,858 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
591 | $422.74 | 9,676 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 4:46 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,099 | $422.74 | 47,588 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-12 4:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
8,048 | $422.74 | 30,740 (Direct) |
View |
| 2024-02-08 Tax Withholding |
2024-02-12 4:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
2,698 | $421.73 | 30,740 (Direct) |
View |
| 2024-02-06 Option Award |
2024-02-08 4:47 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
22,368 | $0 | 66,061 (Direct) |
View |
| 2024-02-06 Option Award |
2024-02-08 4:45 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
21,956 | $0 | 70,593 (Direct) |
View |
| 2024-02-06 Option Award |
2024-02-08 4:43 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
20,794 | $0 | 87,055 (Direct) |
View |
| 2024-02-06 Option Award |
2024-02-08 4:40 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
38,623 | $0 | 41,486 (Direct) |
View |
| 2024-02-06 Option Award |
2024-02-08 4:38 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
61,815 | $0 | 170,526 (Direct) |
View |
| 2024-02-06 Option Award |
2024-02-08 4:33 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
19,608 | $0 | 48,910 (Direct) |
View |
| 2024-02-06 Option Award |
2024-02-08 4:28 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer |
11,037 | $0 | 21,606 (Direct) |
View |
| 2024-02-06 Option Award |
2024-02-08 4:24 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
11,003 | $0 | 24,882 (Direct) |
View |
| 2024-02-06 Option Award |
2024-02-08 4:23 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
26,634 | $0 | 83,330 (Direct) |
View |